Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Amina Mulani

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Chemistry & Biology|November 2, 2010
Fluorescent probes of tissue transglutaminase reveal its association with arterial stiffeningNicolas Chabot, Simon Moreau, Amina Mulani, et al.
Bioorganic Chemistry|July 19, 2014
Acyl transfer mechanisms of tissue transglutaminaseJeffrey W Keillor, Christopher M Clouthier, Kim Y P Apperley, et al.
Organic & Biomolecular Chemistry|June 2, 2012
Site-specific protein propargylation using tissue transglutaminaseClaudio Gnaccarini, Wajih Ben-Tahar, Amina Mulani, et al.
Plos One|February 2, 2011
Plasma membrane factor XIIIA transglutaminase activity regulates osteoblast matrix secretion and deposition by affecting microtubule dynamicsHadil F Al-Jallad, Vamsee D Myneni, Sarah A Piercy-Kotb, et al.
Molecular Cancer Therapeutics|December 16, 2021
RP-3500: A Novel, Potent, and Selective ATR Inhibitor that is Effective in Preclinical Models as a Monotherapy and in Combination with PARP InhibitorsAnne Roulston, Michal Zimmermann, Robert Papp, et al.
Journal of Medicinal Chemistry|February 1, 2024
Discovery of the Potent and Selective ATR Inhibitor Camonsertib (RP-3500)W Cameron Black, Abbas Abdoli, Xiuli An, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Chemistry & Biology|November 2, 2010
Fluorescent probes of tissue transglutaminase reveal its association with arterial stiffeningNicolas Chabot, Simon Moreau, Amina Mulani, et al.
Bioorganic Chemistry|July 19, 2014
Acyl transfer mechanisms of tissue transglutaminaseJeffrey W Keillor, Christopher M Clouthier, Kim Y P Apperley, et al.
Organic & Biomolecular Chemistry|June 2, 2012
Site-specific protein propargylation using tissue transglutaminaseClaudio Gnaccarini, Wajih Ben-Tahar, Amina Mulani, et al.
Plos One|February 2, 2011
Plasma membrane factor XIIIA transglutaminase activity regulates osteoblast matrix secretion and deposition by affecting microtubule dynamicsHadil F Al-Jallad, Vamsee D Myneni, Sarah A Piercy-Kotb, et al.
Molecular Cancer Therapeutics|December 16, 2021
RP-3500: A Novel, Potent, and Selective ATR Inhibitor that is Effective in Preclinical Models as a Monotherapy and in Combination with PARP InhibitorsAnne Roulston, Michal Zimmermann, Robert Papp, et al.
Journal of Medicinal Chemistry|February 1, 2024
Discovery of the Potent and Selective ATR Inhibitor Camonsertib (RP-3500)W Cameron Black, Abbas Abdoli, Xiuli An, et al.
Pageof 1